{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T15:46:58Z","timestamp":1792252018559,"version":"4.4.0"},"reference-count":407,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T00:00:00Z","timestamp":1774051200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["P37275"],"award-info":[{"award-number":["P37275"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["RU5659"],"award-info":[{"award-number":["RU5659"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002428","name":"Austrian Science Fund","doi-asserted-by":"publisher","award":["I6944"],"award-info":[{"award-number":["I6944"]}],"id":[{"id":"10.13039\/501100002428","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["GA 884754"],"award-info":[{"award-number":["GA 884754"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["101160061"],"award-info":[{"award-number":["101160061"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["HORIZON-WIDERA-2023-ACCESS-02"],"award-info":[{"award-number":["HORIZON-WIDERA-2023-ACCESS-02"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["CRC TRR 353"],"award-info":[{"award-number":["CRC TRR 353"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["428858739"],"award-info":[{"award-number":["428858739"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["CO 291\/10-1"],"award-info":[{"award-number":["CO 291\/10-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["471011418"],"award-info":[{"award-number":["471011418"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["461507177"],"award-info":[{"award-number":["461507177"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["461385412"],"award-info":[{"award-number":["461385412"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009187","name":"Medical Research Foundation","doi-asserted-by":"publisher","award":["3G0A9322"],"award-info":[{"award-number":["3G0A9322"]}],"id":[{"id":"10.13039\/501100009187","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009187","name":"Medical Research Foundation","doi-asserted-by":"publisher","award":["3G0I5722"],"award-info":[{"award-number":["3G0I5722"]}],"id":[{"id":"10.13039\/501100009187","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009187","name":"Medical Research Foundation","doi-asserted-by":"publisher","award":["3G0AA824"],"award-info":[{"award-number":["3G0AA824"]}],"id":[{"id":"10.13039\/501100009187","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009187","name":"Medical Research Foundation","doi-asserted-by":"publisher","award":["3G033120"],"award-info":[{"award-number":["3G033120"]}],"id":[{"id":"10.13039\/501100009187","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000951","name":"Cancer Council Victoria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000951","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015803","name":"Tencent","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015803","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Forschung, Technologie und Raumfahrt","doi-asserted-by":"publisher","award":["01EJ2205B"],"award-info":[{"award-number":["01EJ2205B"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Forschung, Technologie und Raumfahrt","doi-asserted-by":"publisher","award":["03VP04260"],"award-info":[{"award-number":["03VP04260"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1020363"],"award-info":[{"award-number":["1020363"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.cell.2026.03.024","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T15:03:30Z","timestamp":1776351810000},"page":"2322-2356","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Cell death in cancer"],"prefix":"10.1016","volume":"189","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1140-5612","authenticated-orcid":false,"given":"Marcus","family":"Conrad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Strasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp J.","family":"Jost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junying","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Vandenabeele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Wahida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cell.2026.03.024_bib1","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1152\/physrev.00002.2021","article-title":"The evolution of regulated cell death pathways in animals and their evasion by pathogens","volume":"102","author":"Tummers","year":"2022","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.cell.2026.03.024_bib2","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/cdd.2008.65","article-title":"Living with death: the evolution of the mitochondrial pathway of apoptosis in animals","volume":"15","author":"Oberst","year":"2008","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cell.2026.03.024_bib3","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/sj.cdd.4400950","article-title":"On the origin, evolution, and nature of programmed cell death: a timeline of four billion years","volume":"9","author":"Ameisen","year":"2002","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cell.2026.03.024_bib4","series-title":"Cellular pathology as based upon physiological and pathological histology; twenty lectures delivered in the Pathological Institute of Berlin during the months of February, March, and April, 1858","author":"Virchow","year":"1860"},{"key":"10.1016\/j.cell.2026.03.024_bib5","doi-asserted-by":"crossref","first-page":"24967","DOI":"10.1038\/scientificamerican11111905-24967supp","article-title":"Old Age","volume":"60","author":"Metchnikoff","year":"1905","journal-title":"Sci. Am."},{"key":"10.1016\/j.cell.2026.03.024_bib6","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib7","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: New dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.cell.2026.03.024_bib9","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.cell.2024.02.009","article-title":"Embracing cancer complexity: Hallmarks of systemic disease","volume":"187","author":"Swanton","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cell.2023.11.044","article-title":"Cell death","volume":"187","author":"Newton","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev-pathmechdis-051022-014433","article-title":"Control of cell death in health and disease","volume":"19","author":"Kayagaki","year":"2024","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.cell.2026.03.024_bib12","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1016\/j.devcel.2024.08.008","article-title":"Cell death: Revisiting the roads to ruin","volume":"59","author":"Green","year":"2024","journal-title":"Dev. Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib13","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1126\/science.abf0529","article-title":"Copper induces cell death by targeting lipoylated TCA cycle proteins","volume":"375","author":"Tsvetkov","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.cell.2026.03.024_bib14","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.ccell.2025.03.031","article-title":"Radiotherapy promotes cuproptosis and synergizes with cuproptosis inducers to overcome tumor radioresistance","volume":"43","author":"Lei","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib15","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.cell.2026.03.024_bib16","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41568-025-00888-7","article-title":"Neutrophil extracellular traps in cancer","volume":"26","author":"Shahzad","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cell.2026.03.024_bib17","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nrneph.2016.71","article-title":"The role of neutrophils and NETosis in autoimmune and renal diseases","volume":"12","author":"Gupta","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.cell.2026.03.024_bib18","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41556-023-01091-2","article-title":"Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis","volume":"25","author":"Liu","year":"2023","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.cell.2026.03.024_bib19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41568-025-00879-8","article-title":"Exploiting metabolic cell death for cancer therapy","volume":"26","author":"Mao","year":"2026","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cell.2026.03.024_bib20","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/procel\/pwae003","article-title":"Metabolic cell death in cancer: ferroptosis, cuproptosis, disulfidptosis, and beyond","volume":"15","author":"Mao","year":"2024","journal-title":"Protein Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib21","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1053\/j.gastro.2017.12.004","article-title":"JTC801 induces pH-dependent death specifically in cancer cells and slows growth of tumors in mice","volume":"154","author":"Song","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cell.2026.03.024_bib22","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41590-017-0013-y","article-title":"Oxeiptosis, a ROS-induced caspase-independent apoptosis-like cell-death pathway","volume":"19","author":"Holze","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cell.2026.03.024_bib23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1196\/annals.1427.014","article-title":"Mitochondrial and nuclear cross talk in cell death: parthanatos","volume":"1147","author":"Andrabi","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.cell.2026.03.024_bib24","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nrm.2017.53","article-title":"The multifaceted roles of PARP1 in DNA repair and chromatin remodelling","volume":"18","author":"Ray Chaudhuri","year":"2017","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.cell.2026.03.024_bib25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41573-024-01060-w","article-title":"DNA damage response inhibitors in cancer therapy: lessons from the past, current status and future implications","volume":"24","author":"Drew","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cell.2026.03.024_bib26","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nature14191","article-title":"Necroptosis and its role in inflammation","volume":"517","author":"Pasparakis","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib27","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2016.58","article-title":"Inflammasomes: mechanism of assembly, regulation and signalling","volume":"16","author":"Broz","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cell.2026.03.024_bib28","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.it.2021.06.001","article-title":"The \u201ccytokine storm\u201d: molecular mechanisms and therapeutic prospects","volume":"42","author":"Karki","year":"2021","journal-title":"Trends Immunol."},{"key":"10.1016\/j.cell.2026.03.024_bib29","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib30","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.cell.2026.03.024_bib31","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nature24297","article-title":"Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition","volume":"551","author":"Hangauer","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib32","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/s41568-024-00737-z","article-title":"Cancer drug-tolerant persister cells: from biological questions to clinical opportunities","volume":"24","author":"Russo","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cell.2026.03.024_bib33","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nature23007","article-title":"Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway","volume":"547","author":"Viswanathan","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib34","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/335440a0","article-title":"Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells","volume":"335","author":"Vaux","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib35","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/348331a0","article-title":"Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2","volume":"348","author":"Strasser","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib36","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1513257","article-title":"Targeting BCL2 with venetoclax in relapsed chronic Lymphocytic leukemia","volume":"374","author":"Roberts","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cell.2026.03.024_bib37","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa2012971","article-title":"Azacitidine and venetoclax in previously untreated acute myeloid leukemia","volume":"383","author":"DiNardo","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cell.2026.03.024_bib38","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41590-022-01132-2","article-title":"Immunogenic cell stress and death","volume":"23","author":"Kroemer","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cell.2026.03.024_bib39","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41568-024-00674-x","article-title":"Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity","volume":"24","author":"Meier","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cell.2026.03.024_bib40","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0092-8674(92)90123-T","article-title":"Induction of apoptosis in fibroblasts by c-myc protein","volume":"69","author":"Evan","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib41","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.cell.2017.08.028","article-title":"Putting p53 in context","volume":"170","author":"Kastenhuber","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib42","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/0092-8674(91)90362-3","article-title":"bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship","volume":"67","author":"Strasser","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib43","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41580-020-0270-8","article-title":"Emerging connectivity of programmed cell death pathways and its physiological implications","volume":"21","author":"Bedoui","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.cell.2026.03.024_bib44","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/s41556-024-01425-8","article-title":"Exploiting ferroptosis vulnerabilities in cancer","volume":"26","author":"Nakamura","year":"2024","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.cell.2026.03.024_bib45","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/s41568-025-00864-1","article-title":"Decoding ferroptosis for cancer therapy","volume":"25","author":"Wahida","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cell.2026.03.024_bib46","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1038\/s43018-025-01037-7","article-title":"Prospects for ferroptosis therapies in cancer","volume":"6","author":"Ubellacker","year":"2025","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.cell.2026.03.024_bib47","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41568-021-00407-4","article-title":"The manipulation of apoptosis for cancer therapy using BH3-mimetic drugs","volume":"22","author":"Diepstraten","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cell.2026.03.024_bib48","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41571-022-00660-y","article-title":"Circulating tumour DNA - looking beyond the blood","volume":"19","author":"Tivey","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.cell.2026.03.024_bib49","first-page":"75","article-title":"Gasdermin pores on extracellular vesicles spread cell death","volume":"25","author":"Flemming","year":"2025","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cell.2026.03.024_bib50","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.2174\/1389200221666200103091753","article-title":"Nanotechnology-based drug delivery, metabolism and toxicity","volume":"20","author":"Malaviya","year":"2019","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.cell.2026.03.024_bib51","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/s43018-025-00986-3","article-title":"The tumor microenvironment\u2019s role in the response to immune checkpoint blockade","volume":"6","author":"Aliazis","year":"2025","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.cell.2026.03.024_bib52","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1002\/1878-0261.12851","article-title":"Targeting immunogenic cell death in cancer","volume":"14","author":"Ahmed","year":"2020","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.cell.2026.03.024_bib53","doi-asserted-by":"crossref","DOI":"10.1126\/science.aat5314","article-title":"The integrated stress response: From mechanism to disease","volume":"368","author":"Costa-Mattioli","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.cell.2026.03.024_bib54","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nrc3380","article-title":"Immunogenic cell death and DAMPs in cancer therapy","volume":"12","author":"Krysko","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cell.2026.03.024_bib55","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/978-3-031-92785-0_8","article-title":"For better or worse: the impact of necrotic cell death modalities","volume":"1481","author":"Vandenabeele","year":"2025","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.cell.2026.03.024_bib56","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ccell.2023.01.010","article-title":"Spatial profiling technologies illuminate the tumor microenvironment","volume":"41","author":"Elhanani","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib57","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41571-021-00579-w","article-title":"Radiotherapy as a tool to elicit clinically actionable signalling pathways in cancer","volume":"19","author":"Petroni","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.cell.2026.03.024_bib58","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.tcb.2024.06.006","article-title":"ADAR1: from basic mechanisms to inhibitors","volume":"35","author":"Rehwinkel","year":"2025","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.cell.2026.03.024_bib59","doi-asserted-by":"crossref","first-page":"7262","DOI":"10.1021\/acs.molpharmaceut.5c01263","article-title":"Targeting the cGAS-STING pathway for cancer immunotherapy: From small-molecule agonists to advanced nanomaterials","volume":"22","author":"Guo","year":"2025","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.cell.2026.03.024_bib60","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41590-019-0313-5","article-title":"Macrophages, rather than DCs, are responsible for inflammasome activity in the GM-CSF BMDC model","volume":"20","author":"Erlich","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cell.2026.03.024_bib61","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/s41586-023-05991-z","article-title":"Structural basis of NINJ1-mediated plasma membrane rupture in cell death","volume":"618","author":"Degen","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib62","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/s41586-021-03218-7","article-title":"NINJ1 mediates plasma membrane rupture during lytic cell death","volume":"591","author":"Kayagaki","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib63","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1038\/s41586-023-06191-5","article-title":"Inhibiting membrane rupture with NINJ1 antibodies limits tissue injury","volume":"618","author":"Kayagaki","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib64","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/j.cell.2024.03.008","article-title":"NINJ1 mediates plasma membrane rupture by cutting and releasing membrane disks","volume":"187","author":"David","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib65","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s41586-025-09741-1","article-title":"SIGLEC12 mediates plasma membrane rupture during necroptotic cell death","volume":"649","author":"Noh","year":"2026","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib66","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nrm3737","article-title":"Regulated necrosis: the expanding network of non-apoptotic cell death pathways","volume":"15","author":"Vanden Berghe","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.cell.2026.03.024_bib67","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41418-023-01237-7","article-title":"MLKL polymerization-induced lysosomal membrane permeabilization promotes necroptosis","volume":"31","author":"Liu","year":"2024","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cell.2026.03.024_bib68","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/cdd.2009.184","article-title":"Necroptosis, necrosis and secondary necrosis converge on similar cellular disintegration features","volume":"17","author":"Vanden Berghe","year":"2010","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cell.2026.03.024_bib69","doi-asserted-by":"crossref","DOI":"10.1038\/nri2531","article-title":"CLEC9A: linking necrosis and immunity","volume":"9","author":"Bell","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cell.2026.03.024_bib70","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/s41418-020-00658-y","article-title":"The intrinsic immunogenic properties of cancer cell lines, immunogenic cell death, and how these influence host antitumor immune responses","volume":"28","author":"Aaes","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cell.2026.03.024_bib71","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abf6290","article-title":"ZBP1-MLKL necroptotic signaling potentiates radiation-induced antitumor immunity via intratumoral STING pathway activation","volume":"7","author":"Yang","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/j.cell.2026.03.024_bib72","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1021\/acschembio.9b00939","article-title":"Radiation-induced lipid peroxidation triggers ferroptosis and synergizes with ferroptosis inducers","volume":"15","author":"Ye","year":"2020","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.cell.2026.03.024_bib73","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.bbrc.2022.09.073","article-title":"Activation of pyroptosis and ferroptosis is involved in radiation-induced intestinal injury in mice","volume":"631","author":"Zhang","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cell.2026.03.024_bib74","first-page":"209","article-title":"Conventional chemotherapy: millions of cures, unresolved therapeutic index","volume":"25","author":"Letai","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cell.2026.03.024_bib75","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/s41570-024-00657-4","article-title":"Assembling a new generation of radiopharmaceuticals with supramolecular theranostics","volume":"8","author":"Moreno-Alc\u00e1ntar","year":"2024","journal-title":"Nat. Rev. Chem."},{"key":"10.1016\/j.cell.2026.03.024_bib76","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S1097-2765(00)00136-2","article-title":"The combined functions of proapoptotic Bcl-2 family members bak and bax are essential for normal development of multiple tissues","volume":"6","author":"Lindsten","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib77","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.cell.2018.04.036","article-title":"Embryogenesis and adult life in the absence of intrinsic apoptosis effectors BAX, BAK, and BOK","volume":"173","author":"Ke","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib78","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/bjc.1972.33","article-title":"Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics","volume":"26","author":"Kerr","year":"1972","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.cell.2026.03.024_bib79","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/284555a0","article-title":"Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation","volume":"284","author":"Wyllie","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib80","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1146\/annurev-immunol-042617-053010","article-title":"Apoptosis and clearance of apoptotic cells","volume":"36","author":"Nagata","year":"2018","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cell.2026.03.024_bib81","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s10495-017-1413-z","article-title":"The immune response to secondary necrotic cells","volume":"22","author":"Sachet","year":"2017","journal-title":"Apoptosis"},{"key":"10.1016\/j.cell.2026.03.024_bib82","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1056\/NEJMra2300923","article-title":"Tumor lysis syndrome","volume":"393","author":"Bociek","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cell.2026.03.024_bib83","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1016\/j.febslet.2010.10.046","article-title":"Secondary necrosis: the natural outcome of the complete apoptotic program","volume":"584","author":"Silva","year":"2010","journal-title":"FEBS Lett."},{"key":"10.1016\/j.cell.2026.03.024_bib84","article-title":"ASC- and caspase-8-dependent apoptotic pathway diverges from the NLRC4 inflammasome in macrophages","volume":"8","author":"Lee","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cell.2026.03.024_bib85","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02842","article-title":"Gasdermin E does not limit apoptotic cell disassembly by promoting early onset of secondary necrosis in jurkat T cells and THP-1 monocytes","volume":"9","author":"Tixeira","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cell.2026.03.024_bib86","doi-asserted-by":"crossref","first-page":"6136","DOI":"10.1002\/j.1460-2075.1995.tb00304.x","article-title":"Bcl-2 and Fas\/APO-1 regulate distinct pathways to lymphocyte apoptosis","volume":"14","author":"Strasser","year":"1995","journal-title":"EMBO J."},{"key":"10.1016\/j.cell.2026.03.024_bib87","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1126\/science.281.5381.1309","article-title":"Mitochondria and apoptosis","volume":"281","author":"Green","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.cell.2026.03.024_bib88","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41580-018-0089-8","article-title":"Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins","volume":"20","author":"Singh","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.cell.2026.03.024_bib89","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1101\/gad.276725.115","article-title":"Inactivation of prosurvival Bcl-2 proteins activates Bax\/Bak through the outer mitochondrial membrane","volume":"30","author":"O\u2019Neill","year":"2016","journal-title":"Genes Dev."},{"key":"10.1016\/j.cell.2026.03.024_bib90","doi-asserted-by":"crossref","DOI":"10.1126\/science.adv4314","article-title":"Structural basis of BAX pore formation","volume":"388","author":"Zhang","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.cell.2026.03.024_bib91","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1002\/j.1460-2075.1995.tb00245.x","article-title":"Cytotoxicity-dependent APO-1 (Fas\/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor","volume":"14","author":"Kischkel","year":"1995","journal-title":"EMBO J."},{"key":"10.1016\/j.cell.2026.03.024_bib92","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0092-8674(00)81266-0","article-title":"FLICE, a novel FADD-homologous ICE\/CED-3-like protease, is recruited to the CD95 (Fas\/APO-1) death--inducing signaling complex","volume":"85","author":"Muzio","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib93","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0092-8674(00)81265-9","article-title":"Involvement of MACH, a novel MORT1\/FADD-interacting protease, in Fas\/APO-1- and TNF receptor-induced cell death","volume":"85","author":"Boldin","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib94","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0092-8674(00)81590-1","article-title":"Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis","volume":"94","author":"Li","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib95","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0092-8674(00)81589-5","article-title":"Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors","volume":"94","author":"Luo","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib96","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/nature08229","article-title":"XIAP discriminates between type I and type II FAS-induced apoptosis","volume":"460","author":"Jost","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib97","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/nature01101","article-title":"Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c\/Apaf-1\/caspase-9 apoptosome","volume":"419","author":"Marsden","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib98","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.1073\/pnas.0401471101","article-title":"Bim is a suppressor of Myc-induced mouse B cell leukemia","volume":"101","author":"Egle","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2026.03.024_bib99","doi-asserted-by":"crossref","first-page":"9333","DOI":"10.1073\/pnas.0403286101","article-title":"Suppression of tumorigenesis by the p53 target PUMA","volume":"101","author":"Hemann","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2026.03.024_bib100","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/cdd.2008.195","article-title":"Puma and to a lesser extent Noxa are suppressors of Myc-induced lymphomagenesis","volume":"16","author":"Michalak","year":"2009","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cell.2026.03.024_bib101","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1083\/jcb.200310041","article-title":"Apaf-1 and caspase-9 do not act as tumor suppressors in myc-induced lymphomagenesis or mouse embryo fibroblast transformation","volume":"164","author":"Scott","year":"2004","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.cell.2026.03.024_bib102","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1126\/science.286.5445.1735","article-title":"Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity","volume":"286","author":"Bouillet","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.cell.2026.03.024_bib103","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1126\/science.1090072","article-title":"p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa","volume":"302","author":"Villunger","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.cell.2026.03.024_bib104","doi-asserted-by":"crossref","first-page":"14907","DOI":"10.1073\/pnas.0606176103","article-title":"Bim and Bad mediate imatinib-induced killing of Bcr\/Abl+ leukemic cells, and resistance due to their loss is overcome by a BH3 mimetic","volume":"103","author":"Kuroda","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2026.03.024_bib105","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1101\/gad.182980.111","article-title":"Anti-apoptotic Mcl-1 is essential for the development and sustained growth of acute myeloid leukemia","volume":"26","author":"Glaser","year":"2012","journal-title":"Genes Dev."},{"key":"10.1016\/j.cell.2026.03.024_bib106","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1101\/gad.232009.113","article-title":"Targeting of MCL-1 kills MYC-driven mouse and human lymphomas even when they bear mutations in p53","volume":"28","author":"Kelly","year":"2014","journal-title":"Genes Dev."},{"key":"10.1016\/j.cell.2026.03.024_bib107","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nature03579","article-title":"An inhibitor of Bcl-2 family proteins induces regression of solid tumours","volume":"435","author":"Oltersdorf","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib108","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nature19830","article-title":"The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models","volume":"538","author":"Kotschy","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib109","first-page":"1","article-title":"E mu-bcl-2 transgene facilitates spontaneous transformation of early pre-B and immunoglobulin-secreting cells but not T cells","volume":"8","author":"Strasser","year":"1993","journal-title":"Oncogene"},{"key":"10.1016\/j.cell.2026.03.024_bib110","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1073\/pnas.1215097110","article-title":"Proapoptotic Bak and Bax guard against fatal systemic and organ-specific autoimmune disease","volume":"110","author":"Mason","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2026.03.024_bib111","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1182\/blood-2014-04-570770","article-title":"Plasmacytomagenesis in E\u03bc-v-abl transgenic mice is accelerated when apoptosis is restrained","volume":"124","author":"Vandenberg","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.cell.2026.03.024_bib112","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1016\/j.celrep.2018.08.048","article-title":"Subtle changes in the levels of BCL-2 proteins cause severe craniofacial abnormalities","volume":"24","author":"Grabow","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.cell.2026.03.024_bib113","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1182\/blood.V98.1.194","article-title":"The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis","volume":"98","author":"Straus","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.cell.2026.03.024_bib114","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1158\/0008-5472.CAN-24-2562","article-title":"FADD functions as an oncogene in Chr11q13.3-amplified head and neck squamous cell carcinoma","volume":"85","author":"Zheng","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.cell.2026.03.024_bib115","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/nm0596-574","article-title":"Involvement of the CD95 (APO-1\/FAS) receptor\/ligand system in drug-induced apoptosis in leukemia cells","volume":"2","author":"Friesen","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2026.03.024_bib116","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1084\/jem.191.1.195","article-title":"Ionizing radiation and chemotherapeutic drugs induce apoptosis in lymphocytes in the absence of Fas or FADD\/MORT1 signaling. Implications for cancer therapy","volume":"191","author":"Newton","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cell.2026.03.024_bib117","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0092-8674(02)00738-9","article-title":"Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression","volume":"109","author":"Pelengaris","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib118","first-page":"5017","article-title":"Paradoxical inhibition of c-myc-induced carcinogenesis by Bcl-2 in transgenic mice","volume":"59","author":"de La Coste","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.cell.2026.03.024_bib119","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.molcel.2015.01.018","article-title":"Limited mitochondrial permeabilization causes DNA damage and genomic instability in the absence of cell death","volume":"57","author":"Ichim","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib120","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/s41418-022-01058-0","article-title":"Sub-lethal signals in the mitochondrial apoptosis apparatus: pernicious by-product or physiological event?","volume":"30","author":"H\u00e4cker","year":"2023","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cell.2026.03.024_bib121","doi-asserted-by":"crossref","DOI":"10.1126\/science.aao6047","article-title":"BAK\/BAX macropores facilitate mitochondrial herniation and mtDNA efflux during apoptosis","volume":"359","author":"McArthur","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.cell.2026.03.024_bib122","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-51496-2","article-title":"Type I interferon signaling induces melanoma cell-intrinsic PD-1 and its inhibition antagonizes immune checkpoint blockade","volume":"15","author":"Holzgruber","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2026.03.024_bib123","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1101\/gad.1940110","article-title":"Apoptosis-promoted tumorigenesis: gamma-irradiation-induced thymic lymphomagenesis requires Puma-driven leukocyte death","volume":"24","author":"Michalak","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.cell.2026.03.024_bib124","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1101\/gad.1940210","article-title":"Apoptosis of leukocytes triggered by acute DNA damage promotes lymphoma formation","volume":"24","author":"Labi","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.cell.2026.03.024_bib125","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1053\/j.gastro.2020.03.017","article-title":"MCL1 is required for maintenance of intestinal homeostasis and prevention of carcinogenesis in mice","volume":"159","author":"Healy","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cell.2026.03.024_bib126","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf2154","article-title":"Programmed necrosis in inflammation: Toward identification of the effector molecules","volume":"352","author":"Wallach","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.cell.2026.03.024_bib127","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1084\/jem.187.9.1477","article-title":"Inhibition of caspases increases the sensitivity of L929 cells to necrosis mediated by tumor necrosis factor","volume":"187","author":"Vercammen","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cell.2026.03.024_bib128","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nchembio711","article-title":"Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury","volume":"1","author":"Degterev","year":"2005","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.cell.2026.03.024_bib129","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1084\/jem.188.5.919","article-title":"Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways","volume":"188","author":"Vercammen","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cell.2026.03.024_bib130","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nchembio.83","article-title":"Identification of RIP1 kinase as a specific cellular target of necrostatins","volume":"4","author":"Degterev","year":"2008","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.cell.2026.03.024_bib131","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.cell.2009.05.037","article-title":"Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation","volume":"137","author":"Cho","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib132","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.cell.2009.05.021","article-title":"Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-alpha","volume":"137","author":"He","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib133","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1126\/science.1172308","article-title":"RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis","volume":"325","author":"Zhang","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.cell.2026.03.024_bib134","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.cell.2011.11.031","article-title":"Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase","volume":"148","author":"Sun","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib135","doi-asserted-by":"crossref","first-page":"5322","DOI":"10.1073\/pnas.1200012109","article-title":"Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis","volume":"109","author":"Zhao","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2026.03.024_bib136","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-23004-3","article-title":"ZBP1 not RIPK1 mediates tumor necroptosis in breast cancer","volume":"12","author":"Baik","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2026.03.024_bib137","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/cr.2015.56","article-title":"Methylation-dependent loss of RIP3 expression in cancer represses programmed necrosis in response to chemotherapeutics","volume":"25","author":"Koo","year":"2015","journal-title":"Cell Res."},{"key":"10.1016\/j.cell.2026.03.024_bib138","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adz9227","article-title":"Aberrant methylation limits antitumoral inflammation in lung adenocarcinoma by restricting RIPK3 expression","volume":"12","author":"Agrawal","year":"2026","journal-title":"Sci. Adv."},{"key":"10.1016\/j.cell.2026.03.024_bib139","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/nrm3683","article-title":"Regulation of RIP1 kinase signalling at the crossroads of inflammation and cell death","volume":"14","author":"Ofengeim","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.cell.2026.03.024_bib140","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/s41422-022-00673-3","article-title":"Nuclear RIPK1 promotes chromatin remodeling to mediate inflammatory response","volume":"32","author":"Li","year":"2022","journal-title":"Cell Res."},{"key":"10.1016\/j.cell.2026.03.024_bib141","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.immuni.2014.09.016","article-title":"The necroptosis adaptor RIPK3 promotes injury-induced cytokine expression and tissue repair","volume":"41","author":"Moriwaki","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.cell.2026.03.024_bib142","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.immuni.2023.05.017","article-title":"Sublethal necroptosis signaling promotes inflammation and liver cancer","volume":"56","author":"Vucur","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.cell.2026.03.024_bib143","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.immuni.2013.06.018","article-title":"The pseudokinase MLKL mediates necroptosis via a molecular switch mechanism","volume":"39","author":"Murphy","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.cell.2026.03.024_bib144","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.celrep.2014.04.026","article-title":"MLKL compromises plasma membrane integrity by binding to phosphatidylinositol phosphates","volume":"7","author":"Dondelinger","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.cell.2026.03.024_bib145","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.molcel.2014.03.003","article-title":"Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3","volume":"54","author":"Wang","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib146","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.molcel.2016.01.011","article-title":"Sequential engagement of distinct MLKL phosphatidylinositol-binding sites executes necroptosis","volume":"61","author":"Quarato","year":"2016","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib147","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.molcel.2018.05.010","article-title":"MLKL requires the inositol phosphate code to execute necroptosis","volume":"70","author":"Dovey","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib148","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020105753","article-title":"Pore formation in regulated cell death","volume":"39","author":"Flores-Romero","year":"2020","journal-title":"EMBO J."},{"key":"10.1016\/j.cell.2026.03.024_bib149","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41580-022-00564-w","article-title":"Pore-forming proteins as drivers of membrane permeabilization in cell death pathways","volume":"24","author":"Vandenabeele","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.cell.2026.03.024_bib150","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1038\/s41418-021-00785-0","article-title":"MLKL in cancer: more than a necroptosis regulator","volume":"28","author":"Martens","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cell.2026.03.024_bib151","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.immuni.2017.06.001","article-title":"MLKL, the protein that mediates necroptosis, also regulates endosomal trafficking and extracellular vesicle generation","volume":"47","author":"Yoon","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.cell.2026.03.024_bib152","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.cell.2017.03.020","article-title":"ESCRT-III acts downstream of MLKL to regulate necroptotic cell death and its consequences","volume":"169","author":"Gong","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib153","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1080\/15548627.2021.1954348","article-title":"CAMK2\/CaMKII activates MLKL in short-term starvation to facilitate autophagic flux","volume":"18","author":"Zhan","year":"2022","journal-title":"Autophagy"},{"key":"10.1016\/j.cell.2026.03.024_bib154","doi-asserted-by":"crossref","DOI":"10.1038\/s42003-017-0007-1","article-title":"Nuclear RIPK3 and MLKL contribute to cytosolic necrosome formation and necroptosis","volume":"1","author":"Weber","year":"2018","journal-title":"Commun. Biol."},{"key":"10.1016\/j.cell.2026.03.024_bib155","article-title":"MLKL as an emerging machinery for modulating organelle dynamics: regulatory mechanisms, pathophysiological significance, and targeted therapeutics","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cell.2026.03.024_bib156","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/s41580-023-00623-w","article-title":"Roles of RIPK1 as a stress sentinel coordinating cell survival and immunogenic cell death","volume":"24","author":"Clucas","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.cell.2026.03.024_bib157","doi-asserted-by":"crossref","first-page":"31268","DOI":"10.1074\/jbc.M113.462341","article-title":"Toll-like receptor 3-mediated necrosis via TRIF, RIP3, and MLKL","volume":"288","author":"Kaiser","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cell.2026.03.024_bib158","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/nature20558","article-title":"RIPK1 counteracts ZBP1-mediated necroptosis to inhibit inflammation","volume":"540","author":"Lin","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib159","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/nature20559","article-title":"RIPK1 inhibits ZBP1-driven necroptosis during development","volume":"540","author":"Newton","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib160","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41586-018-0768-9","article-title":"Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade","volume":"565","author":"Ishizuka","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib161","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/s41586-022-04753-7","article-title":"ADAR1 masks the cancer immunotherapeutic promise of ZBP1-driven necroptosis","volume":"606","author":"Zhang","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib162","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41586-022-04878-9","article-title":"ADAR1 averts fatal type I interferon induction by ZBP1","volume":"607","author":"Jiao","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib163","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/s41586-022-04974-w","article-title":"ADAR1 prevents autoinflammation by suppressing spontaneous ZBP1 activation","volume":"607","author":"de Reuver","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib164","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109858","article-title":"ADAR1 restricts ZBP1-mediated immune response and PANoptosis to promote tumorigenesis","volume":"37","author":"Karki","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.cell.2026.03.024_bib165","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.116314","article-title":"ZBP1 pathway promotes tumor immunogenicity in the combination of anti-HER2 therapy and epigenetic therapy","volume":"44","author":"Wang","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.cell.2026.03.024_bib166","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abo6294","article-title":"ZBP1-dependent inflammatory cell death, PANoptosis, and cytokine storm disrupt IFN therapeutic efficacy during coronavirus infection","volume":"7","author":"Karki","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.cell.2026.03.024_bib167","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.molcel.2019.09.006","article-title":"The diversification of cell death and immunity: Memento Mori","volume":"76","author":"Legrand","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib168","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-05979-8","article-title":"Treatment with mRNA coding for the necroptosis mediator MLKL induces antitumor immunity directed against neo-epitopes","volume":"9","author":"Van Hoecke","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2026.03.024_bib169","doi-asserted-by":"crossref","first-page":"775","DOI":"10.4049\/jimmunol.1900072","article-title":"Immunodominant AH1 antigen-deficient necroptotic, but not apoptotic, Murine cancer cells induce antitumor protection","volume":"204","author":"Aaes","year":"2020","journal-title":"J. Immunol."},{"key":"10.1016\/j.cell.2026.03.024_bib170","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.celrep.2016.03.037","article-title":"Vaccination with necroptotic cancer cells induces efficient anti-tumor immunity","volume":"15","author":"Aaes","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.cell.2026.03.024_bib171","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1126\/science.aad0395","article-title":"RIPK1 and NF-kappaB signaling in dying cells determines cross-priming of CD8(+) T cells","volume":"350","author":"Yatim","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.cell.2026.03.024_bib172","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/s41586-019-1548-x","article-title":"Cleavage of RIPK1 by caspase-8 is crucial for limiting apoptosis and necroptosis","volume":"574","author":"Newton","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib173","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/s41418-022-01094-w","article-title":"Mitochondria and cell death-associated inflammation","volume":"30","author":"Vringer","year":"2023","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cell.2026.03.024_bib174","doi-asserted-by":"crossref","first-page":"e99238","DOI":"10.15252\/embj.201899238","article-title":"Mitochondrial inner membrane permeabilisation enables mtDNA release during apoptosis","volume":"37","author":"Riley","year":"2018","journal-title":"EMBO J."},{"key":"10.1016\/j.cell.2026.03.024_bib175","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/s41586-025-09536-4","article-title":"STING induces ZBP1-mediated necroptosis independently of TNFR1 and FADD","volume":"647","author":"Kelepouras","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib176","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.molcel.2019.02.013","article-title":"Apoptotic caspases suppress type I interferon production via the cleavage of cGAS, MAVS, and IRF3","volume":"74","author":"Ning","year":"2019","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib177","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.cell.2014.11.036","article-title":"Apoptotic caspases suppress mtDNA-induced STING-mediated type I IFN production","volume":"159","author":"White","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib178","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41580-019-0173-8","article-title":"Mitochondria as multifaceted regulators of cell death","volume":"21","author":"Bock","year":"2020","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.cell.2026.03.024_bib179","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1038\/emboj.2012.18","article-title":"IAPs limit activation of RIP kinases by TNF receptor 1 during development","volume":"31","author":"Moulin","year":"2012","journal-title":"EMBO J."},{"key":"10.1016\/j.cell.2026.03.024_bib180","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.molcel.2018.01.027","article-title":"Ubiquitin-mediated regulation of RIPK1 kinase activity independent of IKK and MK2","volume":"69","author":"Annibaldi","year":"2018","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib181","doi-asserted-by":"crossref","DOI":"10.3390\/cells9020406","article-title":"Future therapeutic directions for Smac-Mimetics","volume":"9","author":"Morrish","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.cell.2026.03.024_bib182","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a008730","article-title":"Inhibitor of apoptosis (IAP) proteins-modulators of cell death and inflammation","volume":"5","author":"Silke","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.cell.2026.03.024_bib183","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aad3099","article-title":"The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemia","volume":"8","author":"Brumatti","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cell.2026.03.024_bib184","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1200\/JCO.1996.14.10.2653","article-title":"Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial","volume":"14","author":"Eggermont","year":"1996","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cell.2026.03.024_bib185","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-018-1160-2","article-title":"Sensitization of glioblastoma cells to TRAIL-induced apoptosis by IAP- and Bcl-2 antagonism","volume":"9","author":"Lincoln","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cell.2026.03.024_bib186","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20221156","article-title":"The Z-nucleic acid sensor ZBP1 in health and disease","volume":"220","author":"Maelfait","year":"2023","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cell.2026.03.024_bib187","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s43018-025-00907-4","article-title":"Targeting ADAR1 with a small molecule for the treatment of prostate cancer","volume":"6","author":"Wang","year":"2025","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.cell.2026.03.024_bib188","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1261\/rna.080721.125","article-title":"ZYS-1 is not an ADAR1 inhibitor","volume":"31","author":"Smoak","year":"2025","journal-title":"RNA"},{"key":"10.1016\/j.cell.2026.03.024_bib189","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.ccell.2024.04.004","article-title":"Putting the STING back into BH3-mimetic drugs for TP53-mutant blood cancers","volume":"42","author":"Diepstraten","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib190","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113377","article-title":"Triggering endogenous Z-RNA sensing for anti-tumor therapy through ZBP1-dependent necroptosis","volume":"42","author":"Yang","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.cell.2026.03.024_bib191","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.immuni.2024.04.025","article-title":"A RIPK1-specific PROTAC degrader achieves potent antitumor activity by enhancing immunogenic cell death","volume":"57","author":"Mannion","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.cell.2026.03.024_bib192","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41416-024-02887-1","article-title":"Cancer and treatment specific incidence rates of immune-related adverse events induced by immune checkpoint inhibitors: a systematic review","volume":"132","author":"Jayathilaka","year":"2025","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.cell.2026.03.024_bib193","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1002\/cncr.28144","article-title":"Pronecrotic mixed lineage kinase domain-like protein expression is a prognostic biomarker in patients with early-stage resected pancreatic adenocarcinoma","volume":"119","author":"Colbert","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.cell.2026.03.024_bib194","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1177\/1533034616655909","article-title":"Association of mixed lineage kinase domain-like protein expression with prognosis in patients with colon cancer","volume":"16","author":"Li","year":"2017","journal-title":"Technol. Cancer Res. Treat."},{"key":"10.1016\/j.cell.2026.03.024_bib195","first-page":"15035","article-title":"Mixed lineage kinase domain-like protein is a prognostic biomarker for cervical squamous cell cancer","volume":"8","author":"Ruan","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.cell.2026.03.024_bib196","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41418-018-0122-7","article-title":"Constitutive interferon signaling maintains critical threshold of MLKL expression to license necroptosis","volume":"26","author":"Sarhan","year":"2019","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cell.2026.03.024_bib197","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1016\/j.molcel.2025.06.005","article-title":"MLKL activates the cGAS-STING pathway by releasing mitochondrial DNA upon necroptosis induction","volume":"85","author":"Ding","year":"2025","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib198","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.molcel.2014.10.021","article-title":"RIP3 induces apoptosis independent of pronecrotic kinase activity","volume":"56","author":"Mandal","year":"2014","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib199","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1126\/science.1249361","article-title":"Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis","volume":"343","author":"Newton","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.cell.2026.03.024_bib200","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms7282","article-title":"RIPK3 promotes cell death and NLRP3 inflammasome activation in the absence of MLKL","volume":"6","author":"Lawlor","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2026.03.024_bib201","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.immuni.2016.07.016","article-title":"The pseudokinase MLKL and the kinase RIPK3 have distinct roles in autoimmune disease caused by loss of death-receptor-induced apoptosis","volume":"45","author":"Alvarez-Diaz","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.cell.2026.03.024_bib202","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2020.188357","article-title":"Caspase-8: The double-edged sword","volume":"1873","author":"Mandal","year":"2020","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.cell.2026.03.024_bib203","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/s41586-019-1770-6","article-title":"Caspase-8 is the molecular switch for apoptosis, necroptosis and pyroptosis","volume":"575","author":"Fritsch","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib204","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/ncb2362","article-title":"Caspase 8 inhibits programmed necrosis by processing CYLD","volume":"13","author":"O\u2019Donnell","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.cell.2026.03.024_bib205","doi-asserted-by":"crossref","first-page":"20054","DOI":"10.1073\/pnas.1116302108","article-title":"Toll-like receptors activate programmed necrosis in macrophages through a receptor-interacting kinase-3-mediated pathway","volume":"108","author":"He","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2026.03.024_bib206","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/s41418-024-01286-6","article-title":"ZBP1 and TRIF trigger lethal necroptosis in mice lacking caspase-8 and TNFR1","volume":"31","author":"Solon","year":"2024","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cell.2026.03.024_bib207","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41423-019-0237-x","article-title":"ZBP1 mediates interferon-induced necroptosis","volume":"17","author":"Yang","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.cell.2026.03.024_bib208","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.immuni.2020.04.002","article-title":"FADD and caspase-8 regulate gut homeostasis and inflammation by controlling MLKL- and GSDMD-mediated death of intestinal epithelial cells","volume":"52","author":"Schwarzer","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.cell.2026.03.024_bib209","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020106700","article-title":"Cell death pathways: intricate connections and disease implications","volume":"40","author":"Kist","year":"2021","journal-title":"EMBO J."},{"key":"10.1016\/j.cell.2026.03.024_bib210","doi-asserted-by":"crossref","first-page":"817","DOI":"10.7150\/thno.67932","article-title":"Targeting regulated cell death in tumor nanomedicines","volume":"12","author":"Zeng","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.cell.2026.03.024_bib211","article-title":"Tumour lysis syndrome","volume":"10","author":"Howard","year":"2024","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.cell.2026.03.024_bib212","article-title":"Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches","volume":"10","author":"Tufail","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.cell.2026.03.024_bib213","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.2217\/fon.11.99","article-title":"The prognostic value of histological tumor necrosis in solid organ malignant disease: a systematic review","volume":"7","author":"Richards","year":"2011","journal-title":"Future Oncol."},{"key":"10.1016\/j.cell.2026.03.024_bib214","doi-asserted-by":"crossref","first-page":"7123","DOI":"10.1016\/S0021-9258(17)38364-3","article-title":"Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process","volume":"261","author":"Friedlander","year":"1986","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cell.2026.03.024_bib215","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/358167a0","article-title":"Shigella flexneri induces apoptosis in infected macrophages","volume":"358","author":"Zychlinsky","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib216","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1365-2958.2000.02103.x","article-title":"Salmonella induces macrophage death by caspase-1-dependent necrosis","volume":"38","author":"Brennan","year":"2000","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.cell.2026.03.024_bib217","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0966-842X(00)01936-3","article-title":"Pro-inflammatory programmed cell death","volume":"9","author":"Cookson","year":"2001","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.cell.2026.03.024_bib218","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrmicro2070","article-title":"Pyroptosis: host cell death and inflammation","volume":"7","author":"Bergsbaken","year":"2009","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.cell.2026.03.024_bib219","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","article-title":"The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta","volume":"10","author":"Martinon","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib220","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature10558","article-title":"Non-canonical inflammasome activation targets caspase-11","volume":"479","author":"Kayagaki","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib221","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.cell.2014.04.007","article-title":"Mechanisms and functions of inflammasomes","volume":"157","author":"Lamkanfi","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib222","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/nature15541","article-title":"Caspase-11 cleaves gasdermin D for non-canonical inflammasome signalling","volume":"526","author":"Kayagaki","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib223","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nature15514","article-title":"Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death","volume":"526","author":"Shi","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib224","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nature18629","article-title":"Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores","volume":"535","author":"Liu","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib225","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature18590","article-title":"Pore-forming activity and structural autoinhibition of the gasdermin family","volume":"535","author":"Ding","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib226","doi-asserted-by":"crossref","first-page":"7858","DOI":"10.1073\/pnas.1607769113","article-title":"GsdmD p30 elicited by caspase-11 during pyroptosis forms pores in membranes","volume":"113","author":"Aglietti","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2026.03.024_bib227","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.15252\/embj.201694696","article-title":"GSDMD membrane pore formation constitutes the mechanism of pyroptotic cell death","volume":"35","author":"Sborgi","year":"2016","journal-title":"EMBO J."},{"key":"10.1016\/j.cell.2026.03.024_bib228","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.tibs.2016.10.004","article-title":"Pyroptosis: Gasdermin-mediated programmed necrotic cell death","volume":"42","author":"Shi","year":"2017","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.cell.2026.03.024_bib229","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/ng1829","article-title":"Mutations in the gene encoding pejvakin, a newly identified protein of the afferent auditory pathway, cause DFNB59 auditory neuropathy","volume":"38","author":"Delmaghani","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cell.2026.03.024_bib230","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41586-018-0058-6","article-title":"Cryo-EM structure of the gasdermin A3 membrane pore","volume":"557","author":"Ruan","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib231","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41586-021-03478-3","article-title":"Gasdermin D pore structure reveals preferential release of mature interleukin-1","volume":"593","author":"Xia","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib232","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/s41586-023-05872-5","article-title":"Structural mechanisms for regulation of GSDMB pore-forming activity","volume":"616","author":"Zhong","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib233","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/eji.201747404","article-title":"The Gasdermin-D pore acts as a conduit for IL-1beta secretion in mice","volume":"48","author":"Heilig","year":"2018","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cell.2026.03.024_bib234","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41577-019-0228-2","article-title":"The gasdermins, a protein family executing cell death and inflammation","volume":"20","author":"Broz","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cell.2026.03.024_bib235","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/s41573-021-00154-z","article-title":"Channelling inflammation: gasdermins in physiology and disease","volume":"20","author":"Liu","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.cell.2026.03.024_bib236","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.cell.2020.02.002","article-title":"Structural mechanism for GSDMD targeting by autoprocessed caspases in pyroptosis","volume":"180","author":"Wang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib237","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14128","article-title":"Cleavage of DFNA5 by caspase-3 during apoptosis mediates progression to secondary necrotic\/pyroptotic cell death","volume":"8","author":"Rogers","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2026.03.024_bib238","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature22393","article-title":"Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin","volume":"547","author":"Wang","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib239","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nri3839","article-title":"Perforin and granzymes: function, dysfunction and human pathology","volume":"15","author":"Voskoboinik","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cell.2026.03.024_bib240","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaz7548","article-title":"Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells","volume":"368","author":"Zhou","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.cell.2026.03.024_bib241","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1158\/2326-6066.CIR-20-0525","article-title":"Lighting a Fire: Can We Harness Pyroptosis to Ignite Antitumor Immunity?","volume":"9","author":"Zhang","year":"2021","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.cell.2026.03.024_bib242","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.immuni.2024.03.017","article-title":"Intraepithelial mast cells drive gasdermin C-mediated type 2 immunity","volume":"57","author":"Yang","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.cell.2026.03.024_bib243","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1016\/j.immuni.2025.06.018","article-title":"Gasdermin C cleavage by Cathepsin S modulates Rab7 vesicles in intestinal epithelial cells to amplify anti-helminth immunity","volume":"58","author":"Pandey","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.cell.2026.03.024_bib244","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/s41556-020-0575-z","article-title":"PD-L1-mediated gasdermin C expression switches apoptosis to pyroptosis in cancer cells and facilitates tumour necrosis","volume":"22","author":"Hou","year":"2020","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.cell.2026.03.024_bib245","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/s41422-021-00506-9","article-title":"The metabolite alpha-KG induces GSDMC-dependent pyroptosis through death receptor 6-activated caspase-8","volume":"31","author":"Zhang","year":"2021","journal-title":"Cell Res."},{"key":"10.1016\/j.cell.2026.03.024_bib246","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/s41586-021-04384-4","article-title":"Streptococcal pyrogenic exotoxin B cleaves GSDMA and triggers pyroptosis","volume":"602","author":"Deng","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib247","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41586-022-04717-x","article-title":"Group A Streptococcus induces GSDMA-dependent pyroptosis in keratinocytes","volume":"605","author":"LaRock","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib248","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41586-020-2071-9","article-title":"Gasdermin E suppresses tumour growth by activating anti-tumour immunity","volume":"579","author":"Zhang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib249","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22010426","article-title":"Switching from apoptosis to pyroptosis: Gasdermin-elicited inflammation and antitumor immunity","volume":"22","author":"Tsuchiya","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cell.2026.03.024_bib250","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1158\/2326-6066.CIR-16-0269","article-title":"Inflammasomes and Cancer","volume":"5","author":"Karki","year":"2017","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.cell.2026.03.024_bib251","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/s41590-021-00886-5","article-title":"NLRP3 inflammasome in cancer and metabolic diseases","volume":"22","author":"Sharma","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.cell.2026.03.024_bib252","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.it.2016.09.006","article-title":"Dendritic Cells and Cancer Immunity","volume":"37","author":"Gardner","year":"2016","journal-title":"Trends Immunol."},{"key":"10.1016\/j.cell.2026.03.024_bib253","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201847575","article-title":"The emerging roles of inflammasome-dependent cytokines in cancer development","volume":"20","author":"Van Gorp","year":"2019","journal-title":"EMBO Rep."},{"key":"10.1016\/j.cell.2026.03.024_bib254","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1349-7006.2006.00351.x","article-title":"Identification of DFNA5 as a target of epigenetic inactivation in gastric cancer","volume":"98","author":"Akino","year":"2007","journal-title":"Cancer Sci."},{"key":"10.1016\/j.cell.2026.03.024_bib255","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1038\/sj.onc.1211021","article-title":"Aberrant promoter methylation and tumor suppressive activity of the DFNA5 gene in colorectal carcinoma","volume":"27","author":"Kim","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.cell.2026.03.024_bib256","first-page":"1319","article-title":"Methylation of the DFNA5 gene is frequently detected in colorectal cancer","volume":"32","author":"Yokomizo","year":"2012","journal-title":"Anticancer Res."},{"key":"10.1016\/j.cell.2026.03.024_bib257","doi-asserted-by":"crossref","first-page":"6525","DOI":"10.1007\/s11033-013-2581-8","article-title":"The expression and regulation of DFNA5 in human hepatocellular carcinoma DFNA5 in hepatocellular carcinoma","volume":"40","author":"Wang","year":"2013","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.cell.2026.03.024_bib258","doi-asserted-by":"crossref","first-page":"8049","DOI":"10.1021\/acs.nanolett.9b03245","article-title":"Epigenetics-Based Tumor Cells Pyroptosis for Enhancing the Immunological Effect of Chemotherapeutic Nanocarriers","volume":"19","author":"Fan","year":"2019","journal-title":"Nano Lett."},{"key":"10.1016\/j.cell.2026.03.024_bib259","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/s41418-023-01143-y","article-title":"Distinct GSDMB protein isoforms and protease cleavage processes differentially control pyroptotic cell death and mitochondrial damage in cancer cells","volume":"30","author":"Oltra","year":"2023","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cell.2026.03.024_bib260","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41586-023-05832-z","article-title":"Structural basis for GSDMB pore formation and its targeting by IpaH7.8.","volume":"616","author":"Wang","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib261","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.adg3196","article-title":"Alternative splicing of GSDMB modulates killer lymphocyte-triggered pyroptosis","volume":"8","author":"Kong","year":"2023","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.cell.2026.03.024_bib262","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.ccell.2021.04.011","article-title":"Interleukin-1 in tumor progression, therapy, and prevention","volume":"39","author":"Garlanda","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib263","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.immuni.2019.03.012","article-title":"Interleukin-1 and Related Cytokines in the Regulation of Inflammation and Immunity","volume":"50","author":"Mantovani","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.cell.2026.03.024_bib264","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1182\/blood-2016-12-754994","article-title":"Targeting the interleukin-1 pathway in patients with hematological disorders","volume":"129","author":"de Mooij","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.cell.2026.03.024_bib265","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.4049\/jimmunol.1202769","article-title":"The role of IL-1beta in the early tumor cell-induced angiogenic response","volume":"190","author":"Carmi","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.cell.2026.03.024_bib266","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2014.00114","article-title":"The role IL-1 in tumor-mediated angiogenesis","volume":"5","author":"Voronov","year":"2014","journal-title":"Front. Physiol."},{"key":"10.1016\/j.cell.2026.03.024_bib267","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ccr.2008.10.011","article-title":"Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice","volume":"14","author":"Tu","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib268","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1002\/eji.201041037","article-title":"IL-1beta regulates a novel myeloid-derived suppressor cell subset that impairs NK cell development and function","volume":"40","author":"Elkabets","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cell.2026.03.024_bib269","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1073\/pnas.1812266115","article-title":"Blocking IL-1beta reverses the immunosuppression in mouse breast cancer and synergizes with anti-PD-1 for tumor abrogation","volume":"116","author":"Kaplanov","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.cell.2026.03.024_bib270","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/s41586-020-2079-1","article-title":"A bioorthogonal system reveals antitumour immune function of pyroptosis","volume":"579","author":"Wang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib271","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1158\/2159-8290.CD-19-0672","article-title":"Mutant BRAF and MEK Inhibitors Regulate the Tumor Immune Microenvironment via Pyroptosis","volume":"10","author":"Erkes","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.cell.2026.03.024_bib272","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1172\/JCI35437","article-title":"Treatment of B-RAF mutant human tumor cells with a MEK inhibitor requires Bim and is enhanced by a BH3 mimetic","volume":"118","author":"Cragg","year":"2008","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.cell.2026.03.024_bib273","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/s41591-018-0082-y","article-title":"DPP8\/DPP9 inhibitor-induced pyroptosis for treatment of acute myeloid leukemia","volume":"24","author":"Johnson","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2026.03.024_bib274","doi-asserted-by":"crossref","first-page":"6165","DOI":"10.1016\/j.cell.2024.08.007","article-title":"Small-molecule GSDMD agonism in tumors stimulates antitumor immunity without toxicity","volume":"187","author":"Fontana","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib275","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1002\/cam4.2103","article-title":"Methylation analysis of Gasdermin E shows great promise as a biomarker for colorectal cancer","volume":"8","author":"Ibrahim","year":"2019","journal-title":"Cancer Med."},{"key":"10.1016\/j.cell.2026.03.024_bib276","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-024-02763-3","article-title":"Nanoparticle-mediated cell pyroptosis: a new therapeutic strategy for inflammatory diseases and cancer","volume":"22","author":"Zhao","year":"2024","journal-title":"J. Nanobiotechnology"},{"key":"10.1016\/j.cell.2026.03.024_bib277","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2023.101782","article-title":"Pyroptosis: A road to next-generation cancer immunotherapy","volume":"68","author":"Fang","year":"2023","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.cell.2026.03.024_bib278","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1158\/2326-6066.CIR-24-0834","article-title":"In Situ Delivery of Gasdermin E mRNA Promotes Antitumor Immunity via Creatine-Elicited Type I Interferon Signaling in Monocytes","volume":"13","author":"Li","year":"2025","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.cell.2026.03.024_bib279","article-title":"Oncolytic Parapoxvirus induces Gasdermin E-mediated pyroptosis and activates antitumor immunity","volume":"14","author":"Lin","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2026.03.024_bib280","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aax7969","article-title":"Gasdermin E-mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome","volume":"5","author":"Liu","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.cell.2026.03.024_bib281","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1146\/annurev-cancerbio-030518-055844","article-title":"The hallmarks of ferroptosis","volume":"3","author":"Dixon","year":"2019","journal-title":"Annu. Rev. Cancer Biol."},{"key":"10.1016\/j.cell.2026.03.024_bib282","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41580-025-00843-2","article-title":"Recommendations for robust and reproducible research on ferroptosis","volume":"26","author":"Mishima","year":"2025","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.cell.2026.03.024_bib283","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.cell.2019.04.024","article-title":"The coming decade of cell death research: Five riddles","volume":"177","author":"Green","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib284","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103211","article-title":"Ferroptosis in health and disease","volume":"75","author":"Berndt","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.cell.2026.03.024_bib285","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1016\/j.cell.2022.07.025","article-title":"Sublethal cytochrome c release generates drug-tolerant persister cells","volume":"185","author":"Kalkavan","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib286","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.molcel.2022.03.022","article-title":"Ferroptosis at the intersection of lipid metabolism and cellular signaling","volume":"82","author":"Liang","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib287","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1146\/annurev-biochem-052521-033527","article-title":"Lipid quality control and ferroptosis: From concept to mechanism","volume":"93","author":"Li","year":"2024","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.cell.2026.03.024_bib288","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41589-022-01249-3","article-title":"Identification of essential sites of lipid peroxidation in ferroptosis","volume":"19","author":"von Krusenstiern","year":"2023","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.cell.2026.03.024_bib289","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/biof.5520140123","article-title":"Cloning of phospholipid hydroperoxide glutathione peroxidase (PHGPx) as an anti-apoptotic and growth promoting gene of Burkitt lymphoma cells","volume":"14","author":"Brielmeier","year":"2001","journal-title":"BioFactors"},{"key":"10.1016\/j.cell.2026.03.024_bib290","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.cub.2023.02.060","article-title":"Lipid peroxidation increases membrane tension, Piezo1 gating, and cation permeability to execute ferroptosis","volume":"33","author":"Hirata","year":"2023","journal-title":"Curr. Biol."},{"key":"10.1016\/j.cell.2026.03.024_bib291","doi-asserted-by":"crossref","first-page":"R269","DOI":"10.1016\/j.cub.2023.03.009","article-title":"Ferroptosis: Under pressure!","volume":"33","author":"Wahida","year":"2023","journal-title":"Curr. Biol."},{"key":"10.1016\/j.cell.2026.03.024_bib292","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1038\/s41418-020-00691-x","article-title":"Ferroptotic pores induce Ca2+ fluxes and ESCRT-III activation to modulate cell death kinetics","volume":"28","author":"Pedrera","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cell.2026.03.024_bib293","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/s41556-020-0565-1","article-title":"Ferroptosis occurs through an osmotic mechanism and propagates independently of cell rupture","volume":"22","author":"Riegman","year":"2020","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.cell.2026.03.024_bib294","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1038\/sj.onc.1210796","article-title":"The cystine\/cysteine cycle: a redox cycle regulating susceptibility versus resistance to cell death","volume":"27","author":"Banjac","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.cell.2026.03.024_bib295","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41586-019-1707-0","article-title":"FSP1 is a glutathione-independent ferroptosis suppressor","volume":"575","author":"Doll","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib296","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","article-title":"The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis","volume":"575","author":"Bersuker","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib297","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1535-6108(03)00050-3","article-title":"Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells","volume":"3","author":"Dolma","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib298","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41589-024-01794-z","article-title":"The many paths ascending to ferroptosis","volume":"21","author":"Conrad","year":"2025","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.cell.2026.03.024_bib299","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41568-019-0149-1","article-title":"Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion","volume":"19","author":"Friedmann Angeli","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.cell.2026.03.024_bib300","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ccell.2022.02.003","article-title":"CD8+ T cells and fatty acids orchestrate tumor ferroptosis and immunity via ACSL4","volume":"40","author":"Liao","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib301","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-31218-2","article-title":"Cancer cells dying from ferroptosis impede dendritic cell-mediated anti-tumor immunity","volume":"13","author":"Wiernicki","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2026.03.024_bib302","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/s41556-024-01464-1","article-title":"Zeb1 mediates EMT\/plasticity-associated ferroptosis sensitivity in cancer cells by regulating lipogenic enzyme expression and phospholipid composition","volume":"26","author":"Schwab","year":"2024","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.cell.2026.03.024_bib303","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41586-023-06255-6","article-title":"Phase separation of FSP1 promotes ferroptosis","volume":"619","author":"Nakamura","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib304","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41586-025-09710-8","article-title":"Targeting FSP1 triggers ferroptosis in lung cancer","volume":"649","author":"Wu","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib305","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41586-025-09709-1","article-title":"Lymph node environment drives FSP1 targetability in metastasizing melanoma","volume":"649","author":"Palma","year":"2026","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib306","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.cell.2025.11.014","article-title":"A fin-loop-like structure in GPX4 underlies neuroprotection from ferroptosis","volume":"189","author":"Lorenz","year":"2026","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib307","doi-asserted-by":"crossref","DOI":"10.1038\/s41420-025-02415-x","article-title":"Ferroptosis: CD8+T cells\u2019 blade to destroy tumor cells or poison for self-destruction","volume":"11","author":"Liang","year":"2025","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.cell.2026.03.024_bib308","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1158\/2159-8290.CD-19-0338","article-title":"Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis via Synergistic Repression of SLC7A11","volume":"9","author":"Lang","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.cell.2026.03.024_bib309","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/s41586-022-05022-3","article-title":"A non-canonical vitamin K cycle is a potent ferroptosis suppressor","volume":"608","author":"Mishima","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib310","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1021\/acscentsci.9b01063","article-title":"GTP cyclohydrolase 1\/tetrahydrobiopterin counteract ferroptosis through lipid remodeling","volume":"6","author":"Kraft","year":"2020","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.cell.2026.03.024_bib311","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/s41589-020-0613-y","article-title":"Metabolic determinants of cancer cell sensitivity to canonical ferroptosis inducers","volume":"16","author":"Soula","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.cell.2026.03.024_bib312","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1172\/JCI99032","article-title":"Nano-targeted induction of dual ferroptotic mechanisms eradicates high-risk neuroblastoma","volume":"128","author":"Hassannia","year":"2018","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.cell.2026.03.024_bib313","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.molcel.2021.12.001","article-title":"Persister cancer cells: Iron addiction and vulnerability to ferroptosis","volume":"82","author":"Rodriguez","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib314","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/s41557-020-0513-5","article-title":"CD44 regulates epigenetic plasticity by mediating iron endocytosis","volume":"12","author":"M\u00fcller","year":"2020","journal-title":"Nat. Chem."},{"key":"10.1016\/j.cell.2026.03.024_bib315","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature13148","article-title":"Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy","volume":"509","author":"Mancias","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib316","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.tcb.2024.07.005","article-title":"Copper and iron orchestrate cell-state transitions in cancer and immunity","volume":"35","author":"M\u00fcller","year":"2025","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.cell.2026.03.024_bib317","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41586-025-08974-4","article-title":"Activation of lysosomal iron triggers ferroptosis in cancer","volume":"642","author":"Ca\u00f1eque","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib318","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/s41419-023-06070-x","article-title":"FSP1 confers ferroptosis resistance in KEAP1 mutant non-small cell lung carcinoma in NRF2-dependent and -independent manner","volume":"14","author":"Kim","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cell.2026.03.024_bib319","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-29905-1","article-title":"A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers","volume":"13","author":"Koppula","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2026.03.024_bib320","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108444","article-title":"Concurrent mutations in STK11 and KEAP1 promote ferroptosis protection and SCD1 dependence in lung cancer","volume":"33","author":"Wohlhieter","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.cell.2026.03.024_bib321","doi-asserted-by":"crossref","first-page":"5355","DOI":"10.1158\/0008-5472.CAN-19-0369","article-title":"Stearoyl-CoA desaturase 1 protects ovarian cancer cells from ferroptotic cell death","volume":"79","author":"Tesfay","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.cell.2026.03.024_bib322","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202318014","article-title":"LRP8-mediated selenocysteine uptake is a targetable vulnerability in MYCN-amplified neuroblastoma","volume":"15","author":"Alborzinia","year":"2023","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.cell.2026.03.024_bib323","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s43018-022-00355-4","article-title":"MYCN mediates cysteine addiction and sensitizes neuroblastoma to ferroptosis","volume":"3","author":"Alborzinia","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.cell.2026.03.024_bib324","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.cell.2017.11.048","article-title":"Selenium utilization by GPX4 is required to prevent hydroperoxide-induced ferroptosis","volume":"172","author":"Ingold","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib325","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/s41594-024-01329-z","article-title":"PRDX6 augments selenium utilization to limit iron toxicity and ferroptosis","volume":"31","author":"Fujita","year":"2024","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.cell.2026.03.024_bib326","doi-asserted-by":"crossref","first-page":"4645","DOI":"10.1016\/j.molcel.2024.10.027","article-title":"PRDX6 contributes to selenocysteine metabolism and ferroptosis resistance","volume":"84","author":"Chen","year":"2024","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib327","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.1016\/j.molcel.2024.10.028","article-title":"PRDX6 dictates ferroptosis sensitivity by directing cellular selenium utilization","volume":"84","author":"Ito","year":"2024","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib328","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nchembio.2238","article-title":"Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis","volume":"13","author":"Kagan","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.cell.2026.03.024_bib329","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1152\/physrev.00031.2024","article-title":"Ferroptosis: when metabolism meets cell death","volume":"105","author":"Zheng","year":"2025","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.cell.2026.03.024_bib330","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nchembio.2239","article-title":"ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition","volume":"13","author":"Doll","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.cell.2026.03.024_bib331","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1021\/acschembio.5b00245","article-title":"Human haploid cell genetics reveals roles for lipid metabolism genes in nonapoptotic cell death","volume":"10","author":"Dixon","year":"2015","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.cell.2026.03.024_bib332","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s41586-023-06878-9","article-title":"7-Dehydrocholesterol is an endogenous suppressor of ferroptosis","volume":"626","author":"Freitas","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib333","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-46386-6","article-title":"Inhibition of 7-dehydrocholesterol reductase prevents hepatic ferroptosis under an active state of sterol synthesis","volume":"15","author":"Yamada","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2026.03.024_bib334","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41586-023-06983-9","article-title":"7-Dehydrocholesterol dictates ferroptosis sensitivity","volume":"626","author":"Li","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib335","article-title":"Targeting de novo lipogenesis and the Lands cycle induces ferroptosis in KRAS-mutant lung cancer","volume":"13","author":"Bartolacci","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2026.03.024_bib336","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.ccell.2023.05.001","article-title":"CDKN2A deletion remodels lipid metabolism to prime glioblastoma for ferroptosis","volume":"41","author":"Minami","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib337","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-09277-9","article-title":"A GPX4-dependent cancer cell state underlies the clear-cell morphology and confers sensitivity to ferroptosis","volume":"10","author":"Zou","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.cell.2026.03.024_bib338","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1038\/s41388-018-0315-z","article-title":"The glutathione redox system is essential to prevent ferroptosis caused by impaired lipid metabolism in clear cell renal cell carcinoma","volume":"37","author":"Miess","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.cell.2026.03.024_bib339","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112945","article-title":"HIF-1\u03b1 drives resistance to ferroptosis in solid tumors by promoting lactate production and activating SLC1A1","volume":"42","author":"Yang","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.cell.2026.03.024_bib340","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/s42255-023-00821-y","article-title":"Diverse biological functions of vitamin K: from coagulation to ferroptosis","volume":"5","author":"Mishima","year":"2023","journal-title":"Nat. Metab."},{"key":"10.1016\/j.cell.2026.03.024_bib341","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1146\/annurev-nutr-062320-114541","article-title":"Nutritional and metabolic control of ferroptosis","volume":"42","author":"Mishima","year":"2022","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.cell.2026.03.024_bib342","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/j.cmet.2023.06.014","article-title":"Regulation of VKORC1L1 is critical for p53-mediated tumor suppression through vitamin K metabolism","volume":"35","author":"Yang","year":"2023","journal-title":"Cell Metab."},{"key":"10.1016\/j.cell.2026.03.024_bib343","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-023-06153-9","article-title":"Dehydroascorbic acid sensitizes cancer cells to system xc- inhibition-induced ferroptosis by promoting lipid droplet peroxidation","volume":"14","author":"Ferrada","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.cell.2026.03.024_bib344","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.immuni.2024.03.019","article-title":"Ironing out the role of ferroptosis in immunity","volume":"57","author":"Bell","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.cell.2026.03.024_bib345","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","article-title":"CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy","volume":"569","author":"Wang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib346","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.immuni.2021.05.003","article-title":"Uptake of oxidized lipids by the scavenger receptor CD36 promotes lipid peroxidation and dysfunction in CD8+ T cells in tumors","volume":"54","author":"Xu","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.cell.2026.03.024_bib347","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.cmet.2021.02.015","article-title":"CD36-mediated ferroptosis dampens intratumoral CD8+ T cell effector function and impairs their antitumor ability","volume":"33","author":"Ma","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.cell.2026.03.024_bib348","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109235","article-title":"The glutathione peroxidase Gpx4 prevents lipid peroxidation and ferroptosis to sustain Treg cell activation and suppression of antitumor immunity","volume":"35","author":"Xu","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.cell.2026.03.024_bib349","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.cmet.2021.03.023","article-title":"Metabolic flexibility determines human NK cell functional fate in the tumor microenvironment","volume":"33","author":"Poznanski","year":"2021","journal-title":"Cell Metab."},{"key":"10.1016\/j.cell.2026.03.024_bib350","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41586-022-05443-0","article-title":"Ferroptosis of tumour neutrophils causes immune suppression in cancer","volume":"612","author":"Kim","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib351","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1038\/s41418-021-00814-y","article-title":"Molecular mechanisms of cell death in neurological diseases","volume":"28","author":"Moujalled","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cell.2026.03.024_bib352","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/s41586-020-2623-z","article-title":"Lymph protects metastasizing melanoma cells from ferroptosis","volume":"585","author":"Ubellacker","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib353","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1158\/2159-8290.CD-21-0558","article-title":"Redox Regulation in Cancer Cells during Metastasis","volume":"11","author":"Tasdogan","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.cell.2026.03.024_bib354","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41556-023-01314-6","article-title":"Gut microbial metabolite facilitates colorectal cancer development via ferroptosis inhibition","volume":"26","author":"Cui","year":"2024","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.cell.2026.03.024_bib355","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41556-023-01321-7","article-title":"Microbial regulation of ferroptosis in cancer","volume":"26","author":"Zhang","year":"2024","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.cell.2026.03.024_bib356","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.molcel.2020.05.014","article-title":"Cell death in the origin and treatment of cancer","volume":"78","author":"Strasser","year":"2020","journal-title":"Mol. Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib357","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nm.3048","article-title":"ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets","volume":"19","author":"Souers","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2026.03.024_bib358","unstructured":"NCCN Clinical Practice Guidelines in Oncology: Chronic Lymphocytic Leukemia\/Small Lymphocytic Lymphoma. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cll.pdf."},{"key":"10.1016\/j.cell.2026.03.024_bib359","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1182\/blood.2018882555","article-title":"Efficacy of venetoclax in relapsed chronic lymphocytic leukemia is influenced by disease and response variables","volume":"134","author":"Roberts","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.cell.2026.03.024_bib360","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1182\/blood.2022016040","article-title":"Single-cell multiomics reveal the scale of multilayered adaptations enabling CLL relapse during venetoclax therapy","volume":"140","author":"Thijssen","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.cell.2026.03.024_bib361","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1182\/blood-2017-01-763003","article-title":"Clinicopathological features and outcomes of progression of CLL on the BCL2 inhibitor venetoclax","volume":"129","author":"Anderson","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.cell.2026.03.024_bib362","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1158\/2159-8290.CD-18-1119","article-title":"Acquisition of the recurrent Gly101Val mutation in BCL2 confers resistance to venetoclax in patients with progressive chronic Lymphocytic leukemia","volume":"9","author":"Blombery","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.cell.2026.03.024_bib363","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1158\/2159-8290.CD-16-0313","article-title":"Efficacy and biological correlates of response in a phase II study of venetoclax monotherapy in patients with acute myelogenous leukemia","volume":"6","author":"Konopleva","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.cell.2026.03.024_bib364","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.1007\/s00277-025-06643-0","article-title":"Efficacy and safety of venetoclax plus azacitidine based regimens in the treatment of relapsed or refractory acute myeloid leukemia: a systematic review and meta-analysis","volume":"104","author":"Cai","year":"2025","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.cell.2026.03.024_bib365","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1182\/blood.2024027217","article-title":"Venetoclax and decitabine vs intensive chemotherapy as induction for young patients with newly diagnosed AML","volume":"145","author":"Lu","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.cell.2026.03.024_bib366","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/leu.2015.179","article-title":"Blockade of BCL-2 proteins efficiently induces apoptosis in progenitor cells of high-risk myelodysplastic syndromes patients","volume":"30","author":"Jilg","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.cell.2026.03.024_bib367","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1038\/leu.2014.44","article-title":"BCL-2 family proteins as 5-Azacytidine-sensitizing targets and determinants of response in myeloid malignancies","volume":"28","author":"Bogenberger","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.cell.2026.03.024_bib368","doi-asserted-by":"crossref","first-page":"S644","DOI":"10.1016\/S2152-2650(25)02083-X","article-title":"MDS-1497: Primary analysis of the randomized, phase 3 VERONA study of venetoclax with azacitidine versus placebo with azacitidine in patients with treatment-na\u00efve, intermediate and higher-risk myelodysplastic syndromes","volume":"25","author":"Garcia-Manero","year":"2025","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"10.1016\/j.cell.2026.03.024_bib369","doi-asserted-by":"crossref","DOI":"10.1016\/j.leukres.2024.107602","article-title":"A phase I study of the myeloid cell leukemia 1 (MCL1) inhibitor tapotoclax (AMG 176) in patients with myelodysplastic syndromes after hypomethylating agent failure","volume":"147","author":"Chien","year":"2024","journal-title":"Leuk. Res."},{"key":"10.1016\/j.cell.2026.03.024_bib370","doi-asserted-by":"crossref","first-page":"4844","DOI":"10.1158\/1078-0432.CCR-24-0028","article-title":"A phase 1 first-in-human study of the MCL-1 inhibitor AZD5991 in patients with relapsed\/refractory hematologic malignancies","volume":"30","author":"Desai","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cell.2026.03.024_bib371","doi-asserted-by":"crossref","DOI":"10.1038\/s43856-023-00380-z","article-title":"Selective MCL-1 inhibitor ABBV-467 is efficacious in tumor models but is associated with cardiac troponin increases in patients","volume":"3","author":"Yuda","year":"2023","journal-title":"Commun. Med."},{"key":"10.1016\/j.cell.2026.03.024_bib372","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.cell.2007.01.037","article-title":"Programmed anuclear cell death delimits platelet life span","volume":"128","author":"Mason","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib373","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1038\/s41591-019-0668-z","article-title":"A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity","volume":"25","author":"Khan","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.cell.2026.03.024_bib374","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1182\/blood.2024027117","article-title":"Efficacy of a novel BCL-xL degrader, DT2216, in preclinical models of JAK2-mutated post-MPN AML","volume":"146","author":"Wang","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.cell.2026.03.024_bib375","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-025-01753-8","article-title":"First in human phase 1 study of DT2216, a selective BCL-xL degrader, in patients with relapsed\/refractory solid malignancies","volume":"18","author":"Mahadevan","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.cell.2026.03.024_bib376","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1158\/1078-0432.CCR-21-3811","article-title":"VERONICA: Randomized phase II study of fulvestrant and venetoclax in ER-positive metastatic breast cancer post-CDK4\/6 inhibitors - efficacy, safety, and biomarker results","volume":"28","author":"Lindeman","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cell.2026.03.024_bib377","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/s41418-025-01481-z","article-title":"The BCL-2 protein family: from discovery to drug development","volume":"32","author":"Croce","year":"2025","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cell.2026.03.024_bib378","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nature02067","article-title":"Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1","volume":"426","author":"Opferman","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.cell.2026.03.024_bib379","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1200\/JCO.2011.34.7898","article-title":"Substantial susceptibility of chronic lymphocytic leukemia to BCL2 inhibition: results of a phase I study of navitoclax in patients with relapsed or refractory disease","volume":"30","author":"Roberts","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cell.2026.03.024_bib380","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1038\/leu.2016.213","article-title":"Survival control of malignant lymphocytes by anti-apoptotic MCL-1","volume":"30","author":"Fern\u00e1ndez-Marrero","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.cell.2026.03.024_bib381","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1158\/2159-8290.CD-13-0609","article-title":"Selective BCL-2 inhibition by ABT-199 causes on-target cell death in acute myeloid leukemia","volume":"4","author":"Pan","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.cell.2026.03.024_bib382","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1126\/science.1106114","article-title":"Obligate role of anti-apoptotic MCL-1 in the survival of hematopoietic stem cells","volume":"307","author":"Opferman","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.cell.2026.03.024_bib383","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cell.2012.08.038","article-title":"Relative mitochondrial priming of myeloblasts and normal HSCs determines chemotherapeutic success in AML","volume":"151","author":"Vo","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib384","first-page":"1089","article-title":"Expression of the bcl-2 gene product in follicular lymphoma","volume":"140","author":"Gaulard","year":"1992","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cell.2026.03.024_bib385","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1182\/blood-2018-11-880526","article-title":"Venetoclax plus R- or G-CHOP in non-Hodgkin lymphoma: results from the CAVALLI phase 1b trial","volume":"133","author":"Zelenetz","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.cell.2026.03.024_bib386","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-025-01300-1","article-title":"Phase II study of venetoclax added to bendamustine and obinutuzumab in patients with high-risk follicular lymphoma as front-line therapy: PrE0403","volume":"15","author":"Portell","year":"2025","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.cell.2026.03.024_bib387","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1158\/1078-0432.CCR-20-4890","article-title":"Clinical outcomes in patients with multi-hit TP53 chronic Lymphocytic leukemia treated with ibrutinib","volume":"27","author":"Brieghel","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cell.2026.03.024_bib388","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1182\/blood-2013-11-539726","article-title":"Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia","volume":"123","author":"Rossi","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.cell.2026.03.024_bib389","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.cell.2017.01.018","article-title":"Clonal heterogeneity and tumor evolution: Past, present, and the future","volume":"168","author":"McGranahan","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib390","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/s41576-019-0114-6","article-title":"Resolving genetic heterogeneity in cancer","volume":"20","author":"Turajlic","year":"2019","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.cell.2026.03.024_bib391","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021108389","article-title":"Cancer evolution: Darwin and beyond","volume":"40","author":"Vendramin","year":"2021","journal-title":"EMBO J."},{"key":"10.1016\/j.cell.2026.03.024_bib392","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S1470-2045(24)00070-6","article-title":"Activity of venetoclax in patients with relapsed or refractory chronic lymphocytic leukaemia: analysis of the VENICE-1 multicentre, open-label, single-arm, phase 3b trial","volume":"25","author":"Kater","year":"2024","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.cell.2026.03.024_bib393","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S1470-2045(16)30019-5","article-title":"Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study","volume":"17","author":"Stilgenbauer","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.cell.2026.03.024_bib394","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1200\/JCO.2017.76.6840","article-title":"Venetoclax for patients with Chronic Lymphocytic Leukemia with 17p deletion: Results from the full population of a phase II pivotal trial","volume":"36","author":"Stilgenbauer","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cell.2026.03.024_bib395","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1200\/JCO.21.01181","article-title":"Minimal residual disease dynamics after venetoclax-obinutuzumab treatment: Extended off-treatment follow-up from the randomized CLL14 study","volume":"39","author":"Al-Sawaf","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cell.2026.03.024_bib396","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1182\/blood.2024025525","article-title":"The MURANO study: final analysis and retreatment\/crossover substudy results of VenR for patients with relapsed\/refractory CLL","volume":"145","author":"Kater","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.cell.2026.03.024_bib397","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ccell.2016.06.002","article-title":"RIPK3 restricts myeloid leukemogenesis by promoting cell death and differentiation of leukemia initiating cells","volume":"30","author":"H\u00f6ckendorf","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib398","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adu3313","article-title":"Lymphotoxin alpha eradicates acute myeloid leukemia and simultaneously promotes healthy hematopoiesis in mice","volume":"17","author":"H\u00f6ckendorf","year":"2025","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cell.2026.03.024_bib399","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ccell.2016.01.006","article-title":"Targeting p38 or MK2 enhances the anti-leukemic activity of smac-mimetics","volume":"29","author":"Lalaoui","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib400","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2022.102492","article-title":"Inhibiting the inhibitors: Development of the IAP inhibitor xevinapant for the treatment of locally advanced squamous cell carcinoma of the head and neck","volume":"113","author":"Ferris","year":"2023","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.cell.2026.03.024_bib401","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.cell.2007.10.037","article-title":"IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis","volume":"131","author":"Vince","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.cell.2026.03.024_bib402","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1016\/j.celrep.2014.05.008","article-title":"XIAP restricts TNF- and RIP3-dependent cell death and inflammasome activation","volume":"7","author":"Yabal","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.cell.2026.03.024_bib403","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S1470-2045(20)30327-2","article-title":"Debio 1143 and high-dose cisplatin chemoradiotherapy in high-risk locoregionally advanced squamous cell carcinoma of the head and neck: a double-blind, multicentre, randomised, phase 2 study","volume":"21","author":"Sun","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.cell.2026.03.024_bib404","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ejca.2022.12.015","article-title":"Extended follow-up of a phase 2 trial of xevinapant plus chemoradiotherapy in high-risk locally advanced squamous cell carcinoma of the head and neck: a randomised clinical trial","volume":"183","author":"Tao","year":"2023","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.cell.2026.03.024_bib405","doi-asserted-by":"crossref","first-page":"3209","DOI":"10.1200\/JCO-25-00272","article-title":"Xevinapant or placebo plus platinum-based chemoradiotherapy in unresected locally advanced squamous cell carcinoma of the head and neck (TrilynX): A randomized, phase III study","volume":"43","author":"Bourhis","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cell.2026.03.024_bib406","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1126\/science.adw1836","article-title":"Relative importance of the anti-apoptotic versus apoptosis-unrelated functions of MCL-1 in vivo","volume":"389","author":"Brinkmann","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.cell.2026.03.024_bib407","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41568-022-00529-3","article-title":"The coming decade in precision oncology: six riddles","volume":"23","author":"Wahida","year":"2023","journal-title":"Nat. Rev. Cancer"}],"container-title":["Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867426003259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0092867426003259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T12:34:42Z","timestamp":1779539682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0092867426003259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":407,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0092867426003259"],"URL":"https:\/\/doi.org\/10.1016\/j.cell.2026.03.024","relation":{},"ISSN":["0092-8674"],"issn-type":[{"value":"0092-8674","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cell death in cancer","name":"articletitle","label":"Article Title"},{"value":"Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cell.2026.03.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}